AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,986,753 | +198.1% | 308,502 | +7.8% | 0.38% | +167.1% |
| Q3 2023 | $666,531 | +14.5% | 286,065 | +17.0% | 0.14% | +23.3% |
| Q2 2023 | $582,008 | +42.4% | 244,541 | +10.1% | 0.12% | -1.7% |
| Q1 2023 | $408,754 | +48.0% | 222,149 | +52.9% | 0.12% | -56.0% |
| Q4 2022 | $276,099 | -13.2% | 145,315 | -2.1% | 0.27% | -8.2% |
| Q3 2022 | $318,000 | -31.9% | 148,454 | -10.0% | 0.29% | -17.7% |
| Q2 2022 | $467,000 | -31.3% | 164,906 | +1.1% | 0.36% | +10.9% |
| Q1 2022 | $680,000 | -38.0% | 163,143 | -22.8% | 0.32% | -19.8% |
| Q4 2021 | $1,097,000 | – | 211,319 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |